PLEASE INSERT NAME OF PREPARATION by XWNj40k

VIEWS: 0 PAGES: 4

									                                                                                                                 Blanche Lane
                                                                                                                 South Mimms
                                                                                                                 Potters Bar
                                                                                                                 Hertfordshire EN6 3QG
                                                                                                                 United Kingdom

                                                                                                                 Tel: +44 (0)1707 641000
                                                                                                                 Fax: +44 (0)1707 641050

                                                                                                                 enquiries@nibsc.ac.uk                 http://www.nibsc.ac.uk



      Current availability from NIBSC of candidate influenza vaccine viruses,
     SRD reagents and neuraminidase reagents for use in the 2008/2009 northern
           hemisphere season and the 2009 southern hemisphere season

                                      Update 0113/03 December 23 January 20082009

     Northern Hemisphere 2008/20091, 2


     Candidate influenza vaccine viruses                                                                     NIBSC code
     H1N1
     A/Brisbane/59/2007                                                                                      07/346
     IVR-148 reassortant derived from A/Brisbane/59/2007                                                      07/344
     H3N2
     A/Brisbane/10/2007 wild type virus                                                                       07/250
     NYMC X171B3 reassortant derived from A/Brisbane/10/2007                                                 07/348
     A/Uruguay/716/2007 wild type virus-                                                                     07/354
     NIB-50 reassortant derived from A/Uruguay/716/2007                                                      07/358
     IVR-149 reassortant derived from A/Uruguay/716/2007                                                     07/362
     NYMC X-175C reassortant derived from A/Uruguay/716/2007                                                 07/360
     B
     B/Florida/4/2006                                                                                         08/138
     B/Brisbane/3/2007                                                                                        07/268

1
 WHO recommended composition of influenza virus vaccines for use in the 2008/2009 northern hemisphere
influenza season
http://www.who.int/csr/disease/influenza/recommendations2008_9north/en/index.html
2
    EU recommended composition of influenza virus vaccines for use in the 2008/2009 northern hemisphere
influenza season
http://www.emea.europa.eu/pdfs/human/bwp/13383608en.pdf
3
    Currently being assessed for suitability by the WHO Collaborating Centre CDC, Atlanta, USA




                                                National Institute for Biological Standards and Control                                   1470
      A World Health Organization
        International Laboratory                                                                                                         page 1 of 4
        For Biological Standards


                                    The Institute's UKAS accreditation relates only to our programme of testing for biological medicines.
                                          Full details can be found on our Schedule of Accreditation, which is available on request.
                                                                                                                Blanche Lane
                                                                                                                South Mimms
                                                                                                                Potters Bar
                                                                                                                Hertfordshire EN6 3QG
                                                                                                                United Kingdom

                                                                                                                Tel: +44 (0)1707 641000
                                                                                                                Fax: +44 (0)1707 641050

                                                                                                                enquiries@nibsc.ac.uk                 http://www.nibsc.ac.uk




    Reagents for influenza vaccine standardisation                                                          NIBSC code
    H1N1
    A/Brisbane/59/2007 IVR-148 antigen                                                                      08/100
    A/Brisbane/59/2007 IVR-148 antiserum                                                                    08/112
    H3N2
    A/Brisbane/10/2007-like antigen (NYMC X-175C derived from                                               08/124
    A/Uruguay/716/2007)
    A/Brisbane/10/2007-like antiserum (NYMC X-175C derived from                                             08/13608/246
    A/Uruguay/716/2007)
    B

    B/Florida/4/2006 antigen                                                                                08/140
    B/Florida/4/2006 antiserum                                                                              07/356
    B/Brisbane/3/2007 antigen and antiserum                                                                 Available from TGA4




    Neuraminidase reagents                                                                                  NIBSC code
    N1
    antiserum prepared from A/New Caledonia/20/99                                                           04/230
    N2
    antiserum prepared from A/Wyoming/3/2003                                                                04/258

    B
    NA antiserum prepared from B/Jiangsu/10/2003                                                            04/228
    NA antiserum prepared from B/Malaysia/2506/2004                                                         05/252
    NA antiserum prepared for B/Florida/4/2006 under development                                            To be confirmed



4
 Reagents are available from the Immunobiology Section, Therapeutic Goods Administration Laboratories,
P.O. Box 100, Woden ACT, 2606 Australia and enquiries should be directed to http://www.tga.gov.au or fax
+61 26232 8564.

                                               National Institute for Biological Standards and Control                                   1470
     A World Health Organization
       International Laboratory                                                                                                         page 2 of 4
       For Biological Standards


                                   The Institute's UKAS accreditation relates only to our programme of testing for biological medicines.
                                         Full details can be found on our Schedule of Accreditation, which is available on request.
                                                                                                               Blanche Lane
                                                                                                               South Mimms
                                                                                                               Potters Bar
                                                                                                               Hertfordshire EN6 3QG
                                                                                                               United Kingdom

                                                                                                               Tel: +44 (0)1707 641000
                                                                                                               Fax: +44 (0)1707 641050

                                                                                                               enquiries@nibsc.ac.uk                 http://www.nibsc.ac.uk




Southern Hemisphere 20095




Candidate influenza vaccine viruses                                                                        NIBSC code
H1N1
A/Brisbane/59/2007                                                                                         07/346
IVR-148 reassortant derived from A/Brisbane/59/2007                                                         07/344
H3N2
A/Brisbane/10/2007 wild type virus                                                                          07/250
IVR-147 reassortant derived from A/Brisbane/10/2007                                                         07/246
A/Uruguay/716/2007 wild type virus-                                                                        07/354
NYMC X-175C reassortant derived from A/Uruguay/716/2007                                                    07/360
NIB-50 reassortant derived from A/Uruguay/716/2007                                                         07/358
IVR-149 reassortant derived from A/Uruguay/716/2007                                                        07/362
B
B/Florida/4/2006                                                                                           07/248
B/Brisbane/3/2007                                                                                           07/268

5
 http://www.who.int/csr/disease/influenza/recommendations2009south/en/index.html

http://www.tga.gov.au/committee/aivc.htm
http://www.who.int/entity/csr/disease/influenza/200809Recommendation.pdf




                                              National Institute for Biological Standards and Control                                   1470
    A World Health Organization
      International Laboratory                                                                                                         page 3 of 4
      For Biological Standards


                                  The Institute's UKAS accreditation relates only to our programme of testing for biological medicines.
                                        Full details can be found on our Schedule of Accreditation, which is available on request.
                                                                                                            Blanche Lane
                                                                                                            South Mimms
                                                                                                            Potters Bar
                                                                                                            Hertfordshire EN6 3QG
                                                                                                            United Kingdom

                                                                                                            Tel: +44 (0)1707 641000
                                                                                                            Fax: +44 (0)1707 641050

                                                                                                            enquiries@nibsc.ac.uk                 http://www.nibsc.ac.uk




Reagents for influenza vaccine standardisation                                                          NIBSC code
H1N1
A/Brisbane/59/2007 IVR-148 antigen                                                                      08/100
A/Brisbane/59/2007 IVR-148 antiserum                                                                    08/112
H3N2
A/Brisbane/10/2007-like antigen (NYMC X-175C derived from                                               08/124
A/Uruguay/716/2007)
A/Brisbane/10/2007-like antiserum (NYMC X-175C derived from                                             08/136
A/Uruguay/716/2007)
B
B/Brisbane/3/2007 antigen and antiserum                                                                 Available from TGA3
B/Florida/4/2006 antigen                                                                                08/140
B/Florida/4/2006 antiserum                                                                              07/356




Neuraminidase reagents                                                                                  NIBSC code
N1
antiserum prepared from A/New Caledonia/20/99                                                           04/230
N2
antiserum prepared from A/Wyoming/3/2003                                                               04/258

B
NA antiserum prepared from B/Jiangsu/10/2003                                                             04/228
NA antiserum prepared from B/Malaysia/2506/2004                                                         05/252




                                           National Institute for Biological Standards and Control                                   1470
 A World Health Organization
   International Laboratory                                                                                                         page 4 of 4
   For Biological Standards


                               The Institute's UKAS accreditation relates only to our programme of testing for biological medicines.
                                     Full details can be found on our Schedule of Accreditation, which is available on request.

								
To top